Is the Fixed-Dose Intravenous Trastuzumab Policy Warranted in Limited-Resource Settings? A 29-year-old woman presented with a 2-year history of a slow-growing, indurated, and ulcerated skin mass at ...

A blastic plasmacytoid dendritic-cell neoplasm is a rare tumor with very aggressive clinical behavior and no established treatment. 1 Available treatment options include aggressive multiagent ...

Skeletal involvement by metastatic lung cancer has significant consequences on patient outcomes. In most cases, it is associated with pain, and in a large number of cases, leads to pathological ...

A study suggests a new approach, or, possibly two new approaches against prostate cancer bone metastases: While targeted therapies and anti-cancer immunotherapies have not been especially successful ...

A 53-year-old patient presented with a painless lesion on the left third digit that had been slowly growing for about 20 years. The lesion arose after the patient removed an ingrown nail from the ...

Please provide your email address to receive an email when new articles are posted on . A 68-year-old woman initially presented with intermittent abdominal pain and persisting left hip pain. She gave ...

When prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 percent, once the disease reaches bone, the 5-year ...

Bone is a major site of metastases in prostate cancer. Bone scintigraphy withtechnetium-99m methyl diphosphonate is the most common type of imaging performed to delineate osseous metastases in ...

A 20-year-old man presented to his university's student health clinic with intermittent pain in his right knee that began two months earlier. He had no history of knee injury or surgery and was ...

When prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 percent, once the disease reaches bone, the 5-year ...

When prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 percent, once the disease reaches bone, the 5-year ...